Zdrowie i gospodarka · 07/11/2012

FDA Hosts Public Workshop on Minimum Clinically Important Difference for Orthopaedic Devices

The Food and Drug Administration (FDA) is hosting a public workshop on November 27-28, 2012, to discuss the minimum clinically important difference (MCID) for patient-reported outcome (PRO) instruments used in orthopaedic device-related procedures, with the goal of streamlining evidence-based scientific rationales for regulatory guidance of clinical trials and device study design.

Source: Federal Register — Food and Drug AdministrationOpen original release →

FDA Hosts Public Workshop on Minimum Clinically Important Difference for Orthopaedic Devices

Center for Scientific Review Notice of Closed Meetings

CDC Invites Public Comment on Proposed Data Collection for Public Health Crisis Response

CDC Requests Public Comment on Respiratory Protective Devices Data Collection

Federal Agencies Review Forms Under the Paperwork Reduction Act

Center for Scientific Review Amends Meeting Notice

CDC Invites Public Comment on Proposed Data Collection for Public Health Emergency Preparedness